Cold Spring Harbor Perspectives in Medicine

Scope & Guideline

Advancing the Frontiers of Medical Science

Introduction

Welcome to the Cold Spring Harbor Perspectives in Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cold Spring Harbor Perspectives in Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2157-1422
PublisherCOLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2011 to 2024
AbbreviationCSH PERSPECT MED / Cold Spring Harb. Perspect. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724

Aims and Scopes

Cold Spring Harbor Perspectives in Medicine focuses on providing comprehensive reviews and insights into the latest advancements in medical research, particularly concerning cancer biology, metabolic disorders, and genetic diseases. The journal emphasizes the integration of basic research with clinical applications, aiming to bridge the gap between laboratory findings and therapeutic interventions.
  1. Cancer Biology and Therapeutics:
    The journal extensively covers research on cancer, including its molecular mechanisms, therapeutic strategies, and the development of innovative cancer models. This area represents a core focus, with contributions from various subfields such as immunology, metabolism, and genetic factors influencing tumor progression.
  2. Metabolism and Disease:
    A significant portion of the publications addresses the role of metabolism in various diseases, particularly cancer and diabetes. This includes studies on metabolic pathways, nutrient signaling, and the impact of metabolic dysregulation on disease states.
  3. Genetic and Genomic Insights:
    Research related to genetics, including hereditary conditions and genetic predispositions to diseases, is a prominent theme. The journal explores genetic testing, gene therapy, and the implications of genomic variations on health outcomes.
  4. Animal Models in Biomedical Research:
    The journal highlights the importance of animal models in understanding human diseases. It discusses advancements in modeling techniques and their applications in preclinical research, particularly in cancer and retinal diseases.
  5. Innovative Therapeutic Approaches:
    The journal presents a variety of novel therapeutic strategies, including gene therapy, immunotherapy, and personalized medicine. These contributions reflect ongoing efforts to translate research findings into clinical practice.
The journal has seen a rise in interest in several emerging themes that reflect the evolving landscape of medical research. These trends indicate a growing emphasis on innovative approaches and interdisciplinary studies that integrate various fields of biology and medicine.
  1. Immunotherapy and Cancer Immunology:
    Recent publications have increasingly focused on immunotherapy as a promising treatment approach for various cancers. This trend highlights the importance of understanding the immune system's role in tumor response and the development of novel immune-based therapies.
  2. Cancer Metabolism:
    There is a notable increase in research examining the connection between cancer and metabolism. This emerging theme explores how metabolic pathways influence tumor growth and treatment responses, indicating a shift towards integrating metabolic insights into cancer therapy.
  3. Organoid and 3D Culture Systems:
    The use of organoid models and three-dimensional cultures for studying cancer and other diseases is gaining traction. These innovative models provide more physiologically relevant environments for research, enhancing our understanding of disease mechanisms and therapeutic responses.
  4. Gene Editing Technologies:
    The application of gene editing technologies, particularly CRISPR, is a trending topic in recent publications. Researchers are exploring the potential of these tools for therapeutic development in genetic disorders and cancer, signaling a shift towards more precise and targeted interventions.
  5. Retinal Disease Research:
    Research focused on retinal diseases, particularly advancements in gene therapy and regenerative approaches, is emerging as a significant trend. This reflects a growing interest in addressing vision impairments and understanding the underlying mechanisms of retinal degeneration.

Declining or Waning

While Cold Spring Harbor Perspectives in Medicine has a robust focus on current medical research trends, certain themes have shown a decline in frequency within recent publications. This waning interest may reflect shifts in research priorities or advancements that have rendered previous areas less prominent.
  1. Influenza Research:
    Research related to influenza viruses and their clinical implications has become less prominent in recent publications. This decline may be attributed to the increasing focus on other viral diseases, particularly in the context of the COVID-19 pandemic.
  2. Traditional Cancer Epidemiology:
    While cancer biology remains a core focus, traditional epidemiological studies that primarily analyze population-level data have seen a reduction in emphasis. This may be due to a shift towards more mechanistic studies that explore molecular pathways and treatments.
  3. Basic Mechanisms of Inflammation:
    Discussions surrounding basic mechanisms of inflammation, particularly those not directly linked to specific diseases, appear to be waning. The focus has shifted more towards targeted therapeutic strategies that address inflammation within the context of specific diseases.

Similar Journals

Discovery Medicine

Empowering the medical community with cutting-edge findings.
Publisher: DISCOVERY MEDICINEISSN: 1539-6509Frequency: 6 issues/year

Discovery Medicine, an esteemed journal published by Discovery Medicine, serves as a vital platform within the field of general medicine, dedicated to advancing knowledge through high-quality research and innovative insights. With its ISSN 1539-6509 and E-ISSN 1944-7930, this journal boasts an impressive Scopus ranking of #29 out of 529 in the general medicine category, positioning it at the 94th percentile, indicating its significant contribution to the medical sciences. While operating as a subscription-based journal, Discovery Medicine fosters an environment where researchers and professionals can disseminate their findings and engage with cutting-edge developments in medicine. Spanning topics that bridge clinical practice and healthcare advancements, this journal aims to inform, challenge, and inspire the medical community. The journal has converged its volumes from 2006 to 2007 and again from 2009 to 2018, highlighting its sustained commitment to excellence even as coverage has temporarily discontinued in Scopus. Situated at 10 Gerard Ave, Ste 201, Timonium, MD 21093, Discovery Medicine continues to be a cornerstone for medical scholars, offering a rich repository of knowledge essential for ongoing research and practical applications.

MOLECULAR GENETICS AND METABOLISM

Pioneering Research at the Intersection of Genes and Metabolism
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1096-7192Frequency: 12 issues/year

MOLECULAR GENETICS AND METABOLISM, published by Academic Press Inc Elsevier Science, is a distinguished journal that has been at the forefront of advancing research since its inception in 1998. This journal, boasting both ISSN 1096-7192 and E-ISSN 1096-7206, focuses on the intricate interplay between molecular genetics and metabolic processes, making it an invaluable resource for researchers in the fields of biochemistry, endocrinology, and genetics. Recognized for its impact, it ranks in the Q1 and Q2 quartiles across multiple categories in the latest rankings, enhancing its reputation amongst scholars and professionals. With a commitment to disseminating cutting-edge research, it encourages innovative studies and comprehensive reviews that contribute to our understanding of gene function and metabolism. Open access options provide unrestricted access to its significant findings, further solidifying its role as a leading platform for scientific discourse. As it continues to thrive in the academic community, MOLECULAR GENETICS AND METABOLISM serves as a catalyst for novel insights and advancements in molecular biology.

NEOPLASMA

Illuminating the Pathways of Oncology
Publisher: AEPRESS SROISSN: 0028-2685Frequency: 6 issues/year

NEOPLASMA is a prominent journal published by AEPRESS SRO, dedicated to the multifaceted field of oncology and cancer research. Since its inception in 1957, this esteemed publication has served as a vital platform for advancing the understanding of neoplastic diseases, disseminating high-quality research findings that contribute to clinical and laboratory advancements. Operating under a robust framework of peer review, NEOPLASMA holds significant credibility, as evidenced by its Q2 ranking in the Medicine (miscellaneous) category and Q3 rankings in both Cancer Research and Oncology for 2023. Furthermore, with an ISSN of 0028-2685 and E-ISSN 1338-4317, the journal fosters accessibility to valuable scientific content despite the absence of open access options. Positioned in Bratislava, Slovakia, NEOPLASMA continues to attract a global readership, making substantial contributions to the fields of biochemistry, genetics, and molecular biology as highlighted by its Scopus rankings. This journal is essential reading for researchers, professionals, and students looking to stay abreast of the latest developments in cancer research and treatment strategies.

Genes & Diseases

Advancing knowledge at the intersection of genetics and disease.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

Byulleten Sibirskoy Meditsiny

Bridging Research and Clinical Practice in Molecular Medicine
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Transforming Knowledge in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

MOLECULAR ASPECTS OF MEDICINE

Transforming Insights into Molecular Health Solutions
Publisher: ELSEVIERISSN: 0098-2997Frequency: 6 issues/year

MOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.

MedComm

Elevating Knowledge in Biochemistry and Beyond
Publisher: WILEYISSN: Frequency: 4 issues/year

MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Advancing the Frontiers of Biological and Medical Research
Publisher: SPRINGERISSN: 0007-4888Frequency: 12 issues/year

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

Journal of Biomedical Research

Pioneering Insights in Biochemistry, Genetics, and Molecular Biology
Publisher: NANJING MEDICAL UNIVISSN: 1674-8301Frequency: 6 issues/year

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.